May 19-21, 2015

The Asia Biotech Invest is Hong Kong's life science investment showcase where biotech and medtech companies present their company and current project pipeline to an audience of Hong Kong, China based investors which include PE, Big Pharma, institutional investors, asset managers, angel, and VC. Last year, the event welcomed 222 attendees, 58% of which were from the investor side, for 2015. The Asia Biotech Invest was in its 3rd year running and was part of the 'Biotech Invest' series of events co-organized by AusBiotech and Beacon Events Hong Kong.

The programme for this year focused on 5 key themes:

· Global Aging Population – and its effect on the healthcare spending
· New Technologies allowing for better, more effective treatments
· The impact of Emerging markets expanding their healthcare systems.
· The growing prevalence of life style diseases and their related health impacts
· The high level of merger and acquisition activity currently happening in the market place